Stay connected and up-to-date on the latest news and reports. It’s never been easier to know what’s going on in digital health.
It's been another month of great events at HealthXL, with topics ranging from ‘DTx Reimbursement: Navigating Medicare & Medicaid Coverage’ to ‘Quantifying the Benefits of Digital Biomarkers in Pharma’.
Read moreIn recent years, medical affairs has slowly been brought into the digital era with the introduction of tracking tools and new virtual channels for communication with health care practitioners HCPs. Patients' needs and expectations are also changing rapidly.
Read moreWith marketing leaders from across leading pharma organisations, Steve Peretz, Healthcare Practice Lead, Digital Products, Appnovation and Angela Rosales, Group Director, Strategy, Appnovation, led the session to share key insights into evolving product approaches with an ecosystem strategy, empower
Read moreThis month, experts from the HealthXL community led meetings on topics ranging from accounting for cultural differences in digital mental health services to reducing financial toxicity in oncology. In this article, Tess gives her top five meeting takeaways from July.
Read moreDigital technology is poised to change healthcare. In this webinar, the panel explored key challenges that lie ahead for this specialty and developments they anticipate to take place over the next 10-15 years as we collectively navigate a path towards a unified, digitally enabled healthcare system.
Read moreThe surging growth in digital health over the last decade may have slowed, but the potential of digital to transform healthcare remains. Digital health companies alongside pharma, MedTech, and other key stakeholders must come together and form strategic partnerships that play to their strengths.
Read moreThe path to achieving digital health compliance in software as a medical device (SaMD) and digital health product development can feel like walking a tightrope. With compliance accounting for about 50% of development spend, the task is significant. What can we do about this?
Read moreAs AI reshapes the landscape of healthcare and life sciences, keeping abreast of emerging trends, breakthrough technologies, and innovative applications has become crucial. To help you stay ahead of the curve, we're thrilled to launch our "AI in Healthcare and Life Sciences Community".
Read morePride month has come around again. Companies' logos are more colourful, and what were once protests for equal rights have become parades and celebrations in many parts of the world. Yet, LGBTQIA+ communities still face discrimination within many facets of life; especially when accessing healthcare.
Read morePride month has come around again. Companies' logos are more colourful, and what were once protests for equal rights have become parades and celebrations in many parts of the world. Yet, LGBTQIA+ communities still face discrimination within many facets of life; especially when accessing healthcare.
Read moreIt's been another month of great events at HealthXL. Our Boston Global Gathering was a roaring success. We also hosted many virtual roundtables and masterclasses on a number of topics. Additionally, we ran a great webinar on what pharma and MedTech can learn from each other in digital health.
Read moreHealthXL held its second Global Gathering of the year, in collaboration with Takeda, around the theme of Pharma 3.0: The Next Frontier of Digital Health. The event gathered senior leaders from across the pharmaceutical, MedTech and digital health industries, as well as investors and academics.
Read moreIn this week’s blog, guest author Ahmed Albaiti (Principal, ZS), makes a case for why the recent wave of bad news in digital health may just be the focused push that the industry needs.
Read moreIn the recent years, patient engagement has gained great popularity in healthcare. The most impactful and adoptable solutions come from involving patient experts, key opinion leaders and other key stakeholders in a collaborative 'co-creation' process.
Read moreOur HealthXL meetings in April covered everything from ‘Data Monetisation for MedTech Companies’ to ‘The Potential of OTC DTx Solutions’. To make sure you’re not missing out on the top insights from our communities, and get a sneak peak at some of the conversations, here are my top five takeaways.
Read moreDTx solutions have been developed, theoretically, to remove many of the barriers associated with traditional care models and be more scalable and readily available. However, these solutions are not always accessible or inclusive for the populations that could benefit from them the most.
Read morePharma-DTx partnerships can be a good strategy when both the pharma and the DTx companies speak the same language. While successful pilots have been demonstrated, there are challenges in scaling and sustaining innovations that generate value and return on investment (ROI) for pharma companies.
Read more